Main Street Financial Solutions’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-4,407
Closed -$277K – 630
2026
Q1
$277K Sell
4,407
-1,950
-31% -$156K 0.02% 468
2025
Q4
$606K Sell
6,357
-1,912
-23% -$187K 0.05% 307
2025
Q3
$807K Buy
8,269
+713
+9% +$73.8K 0.05% 289
2025
Q2
$812K Buy
7,556
+1,971
+35% +$199K 0.06% 258
2025
Q1
$563K Buy
5,585
+1,152
+26% +$116K 0.05% 292
2024
Q4
$396K Buy
4,433
+1,492
+51% +$131K 0.04% 330
2024
Q3
$246K Buy
2,941
+78
+3% +$6.15K 0.02% 465
2024
Q2
$220K Buy
+2,863
New +$210K 0.02% 494

Other funds holding BSX

Main Street Financial Solutions's BSX Position: Q2 2026 in Review

Main Street Financial Solutions sold out of Boston Scientific (BSX) in Q2 2026, closing a stake of 4,407 shares — an estimated $277K sold.

Main Street Financial Solutions first reported a position in BSX in Q2 2024 and held it in 8 quarters. The position peaked at $812K in Q2 2025. 1,487 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Main Street Financial Solutions reported no remaining Boston Scientific position as of Q2 2026 after selling out during the quarter.
  • Main Street Financial Solutions sold 4,407 Boston Scientific shares in Q2 2026, an estimated $277K.
  • Main Street Financial Solutions first reported a position in Boston Scientific in Q2 2024 and held it in 8 quarters.
  • Main Street Financial Solutions's Boston Scientific position peaked at $812K in Q2 2025.
  • 1,487 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Main Street Financial Solutions's 13F filing for Q2 2026, filed 7 Aug 2026.